Borowski Christine 4
4 · VYNE Therapeutics Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Borowski Christine
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-01+40,000→ 40,000 totalExercise: $2.33Exp: 2033-12-31→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date.